The disease symptoms and treatments

Multiple sclerosis (MS) is the most common neurological disorder among young adults. It is an auto-immune disease in which the body attacks its own tissues. The immune attack in MS targets the central nervous system. The lesions are well-localised and are called “plaques”.

News

05.06.18

Focus on MS

The theme this year is 'Research'. In Belgium, the Belgian Charcot Foundation guarantees quality and continuity for more than 30 years with more than 200 researchers from the 23 recognized research centers.

Make a gift

20 km of Brussels run or support

Support an action

Start your action

Leave a legacy

Laureates of Charcot Fund 2018

All laureates

Grant

€ 60,000 € / 2 years

Prof. Dr. Geert van Loo and Prof. Dr. Mohamed Lamkanfi

The project

Microglia inflammasome activation in MS pathology
VIB / UGent
Detail of the grant

Grant

€ 30,000 / 2 years

Prof. Dr. Peter Ponsaerts and Dr. Debbie Le Blon

The project

Application of human 3D brain organoids to evaluate the potency of interleukin 13 for modulation of detrimental microglia and macrophage immune responses
Laboratory of Experimental Hematology - UAntwerpen
Detail of the grant

Grant

€ 25,000

Prof. Dr. Niels Hellings, Prof. Dr. Anitha Ethirajan and Prof. Dr. Tanja Junkers

The project

Smart nanoparticles for bioimaging disease activity in progressive multiple sclerosis
BIOMED & Imo-Imomec - UHasselt
Detail of the grant

Grant

€ 39,000 / 2 years

Prof. Dr. Jerome Hendriks and Dr. Jeroen Bogie

The project

Fatty acid metabolism in control of the phenotype of foamy phagocytes in MS
BIOMED - UHasselt
Detail of the grant

Grant

€ 30,000 and € 30,000

Dr. Bieke Broux and Prof. Dr. Georges Leclercq

The project

Innate lymphoid cells in multiple sclerosis: implications of genetic risk variants
BIOMED/UHasselt and UGent
Detail of the grant

Grant

€ 30,000 / 2 years

Prof. Dr. Vincent van Pesch and his team

The project

The neuroinflammatory role of micro-RNAs in extracellular vesicles: biomarkers and therapeutic tools for the immune dysregulation in Multiple Sclerosis
Unit of Neurochemistry- Cliniques Universitaires St Luc
Detail of the grant

Grant

€ 59,005

Prof. Dr. Nathalie Cools

The project

Targeted tolerance in multiple sclerosis: Development of transgenic T cell receptor-engineered regulatory T cells recognizing myelin basic protein
Laboratorium voor Experimentele Hematologie- UAntwerpen
Detail of the grant

Grant

€ 40,000 / 2 years

Dr. Tim Vanmierlo

The project

Boosting second messengers – a novel approach to stimulate repair in MS
BIOMED- UHasselt
Detail of the grant

Last newsletter

Twice a year, the Charcot Foundation publishes a Bulletin which wants to be the objective reflection of research and last acquisitions in Multiple sclerosis as well in the field of our knowledge of the disease as of the new treatments under study

MAY 2018